Noonan syndrome: clinical features, diagnosis, and management guidelines
- PMID: 20876176
- DOI: 10.1542/peds.2009-3207
Noonan syndrome: clinical features, diagnosis, and management guidelines
Abstract
Noonan syndrome (NS) is a common, clinically and genetically heterogeneous condition characterized by distinctive facial features, short stature, chest deformity, congenital heart disease, and other comorbidities. Gene mutations identified in individuals with the NS phenotype are involved in the Ras/MAPK (mitogen-activated protein kinase) signal transduction pathway and currently explain ∼61% of NS cases. Thus, NS frequently remains a clinical diagnosis. Because of the variability in presentation and the need for multidisciplinary care, it is essential that the condition be identified and managed comprehensively. The Noonan Syndrome Support Group (NSSG) is a nonprofit organization committed to providing support, current information, and understanding to those affected by NS. The NSSG convened a conference of health care providers, all involved in various aspects of NS, to develop these guidelines for use by pediatricians in the diagnosis and management of individuals with NS and to provide updated genetic findings.
Similar articles
-
Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.Horm Res. 2009;71(4):185-93. doi: 10.1159/000201106. Epub 2009 Mar 4. Horm Res. 2009. PMID: 19258709 Review.
-
Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.Clin Genet. 2007 Aug;72(2):150-5. doi: 10.1111/j.1399-0004.2007.00839.x. Clin Genet. 2007. PMID: 17661820
-
Noonan syndrome, the Ras-MAPK signalling pathway and short stature.Horm Res. 2009 Apr;71 Suppl 2:64-70. doi: 10.1159/000192439. Epub 2009 Apr 29. Horm Res. 2009. PMID: 19407499 Review.
-
Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.Clin Genet. 2009 Dec;76(6):524-34. doi: 10.1111/j.1399-0004.2009.01233.x. Epub 2009 Oct 21. Clin Genet. 2009. PMID: 19845691
-
Noonan syndrome: introduction and basic clinical features.Horm Res. 2009 Dec;72 Suppl 2:3-7. doi: 10.1159/000243772. Epub 2009 Dec 22. Horm Res. 2009. PMID: 20029230
Cited by
-
Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies.Pediatr Cardiol. 2016 Dec;37(8):1539-1547. doi: 10.1007/s00246-016-1468-6. Epub 2016 Aug 23. Pediatr Cardiol. 2016. PMID: 27554254
-
Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.Front Endocrinol (Lausanne). 2022 Aug 18;13:951331. doi: 10.3389/fendo.2022.951331. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060964 Free PMC article. Review.
-
The Effect of Growth Hormone Therapy on Cardiac Outcomes in Noonan Syndrome: Long Term Follow-up Results.J Clin Res Pediatr Endocrinol. 2022 Dec 1;14(4):422-432. doi: 10.4274/jcrpe.galenos.2022.2022-12-13. Epub 2022 Jul 21. J Clin Res Pediatr Endocrinol. 2022. PMID: 35859537 Free PMC article.
-
Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.Circulation. 2018 Nov 20;138(21):e653-e711. doi: 10.1161/CIR.0000000000000606. Circulation. 2018. PMID: 30571578 Free PMC article. Review.
-
Giant cell lesion of the jaw as a presenting feature of Noonan syndrome.BMJ Case Rep. 2018 May 30;2018:bcr2017224115. doi: 10.1136/bcr-2017-224115. BMJ Case Rep. 2018. PMID: 29848529 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous